We are live on ! Find out more
SOCM

SR One Capital Management Portfolio holdings

AUM $915M
1-Year Est. Return 209.71%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+209.71%
3 Year Est. Return
+484.66%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$232M
AUM Growth
-$36.6M
Cap. Flow
-$59.4M
Cap. Flow %
-25.61%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$59.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$125M 53.81%
3,946,630
-1,553,377
-28% -$59.4M
DSGN icon
2
Design Therapeutics
DSGN
$915M
$41.1M 17.73%
6,526,476
– –
MLYS icon
3
Mineralys Therapeutics
MLYS
$2.41B
$30.6M 13.19%
1,794,600
– –
SPRY icon
4
ARS Pharmaceuticals
SPRY
$591M
$26.9M 11.59%
4,012,903
– –
EFTR
5
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$5.59M 2.41%
272,885
– –
NKTX icon
6
Nkarta
NKTX
$167M
$2.92M 1.26%
1,333,333
– –

Similar funds

PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
SC
Sierra Capital Miami, Florida $918M AUM 8.25% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
FFL
Flat Footed LLC Wilson, Wyoming $920M AUM 86.47% 1-Year Est. Return

SR One Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, SR One Capital Management held 6 positions worth $232M, down 14% from $268M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SR One Capital Management withdrew a net $59.4M in Q2 2023, reducing 1 holding. Its largest reduction was Arcellx, cutting an estimated $59.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SR One Capital Management's biggest Q2 2023 reduction was Arcellx, cutting an estimated $59.4M.
  • SR One Capital Management's ten largest holdings make up 100% of its $232M portfolio in Q2 2023.
  • SR One Capital Management opened 0 new positions and closed 0 in Q2 2023.
  • SR One Capital Management's portfolio value fell 14% quarter-over-quarter to $232M.

Based on SR One Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.